Goldman Sachs’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $28.1M | Buy |
|
|||||
|
2024
Q3 | $11.4M | Sell |
|
|||||
|
2024
Q2 | $16.1M | Buy |
|
|||||
|
2024
Q1 | $11.6M | Buy |
|
|||||
|
2023
Q4 | $11.8M | Sell |
|
|||||
|
2023
Q3 | $12.3M | Sell |
|
|||||
|
2023
Q2 | $47.1M | Buy |
|
|||||
|
2023
Q1 | $29.6M | Sell |
|
|||||
|
2022
Q4 | $35.7M | Buy |
|
|||||
|
2022
Q3 | $32.1M | Buy |
|
|||||
|
2022
Q2 | $21M | Sell |
|
|||||
|
2022
Q1 | $28.5M | Buy |
|
|||||
|
2021
Q4 | $15.1M | Buy |
|
|||||
|
2021
Q3 | $4.7M | Sell |
|
|||||
|
2021
Q2 | $5.66M | Buy |
|
|||||
|
2021
Q1 | $2.97M | Sell |
|
|||||
|
2020
Q4 | $3.71M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $2.02M | Buy |
|